"The immunological orchestra in cancer"

Enhancement of activation-induced apoptosis of lymphocytes by the cytotoxic ribonuclease onconase (Ranpirnase).

International journal of oncology·2002

A phase II trial of weekly intravenous ranpirnase (Onconase), a novel ribonuclease in patients with metastatic kidney cancer.

Investigational new drugs·2001

Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma.

Blood·2001

Induction of differentiation of leukaemic (HL-60) or prostate cancer (LNCaP, JCA-1) cells potentiates apoptosis triggered by onconase.

Cell proliferation·2000

Enhanced cellular radiation sensitivity of androgen-independent human prostate tumor cells by onconase.

Anticancer research·2000

Tumoricidal effects of onconase on various tumors.

Journal of surgical oncology·2000

Activated macrophage hybridomas secreting a cytotoxic factor.

Journal of immunopharmacology·1986

Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.

Journal of immunopharmacology·1986

Hemopoietic effects of intravenous soluble glucan administration.

Journal of immunopharmacology·1986

Suppression of spontaneous insulin-dependent diabetes in BB rats by administration of ciamexone.

Journal of immunopharmacology·1986

Stimulation of hematopoiesis in untreated and cyclophosphamide treated mice by the inhibition of prostaglandin synthesis.

Journal of immunopharmacology·1986

Therapeutic effect of endogenous tumor necrosis factor on ascites Meth A sarcoma.

Journal of immunopharmacology·1986

Tertiary lymphoid structures as biomarkers and therapeutic targets in neoadjuvant cancer immunotherapy.

Frontiers in immunology·2026

The hidden tumour: giant anterior mediastinal thymolipoma, an incidental finding.

Polish journal of pathology : official journal of the Polish Society of Pathologists·2026

FADS1-mediated Efferocytosis in Tumor-Associated Macrophages Shapes an Immunosuppressive Microenvironment in Gastric Cancer.

Cellular and molecular life sciences : CMLS·2026

The tumoural landscape of lymphocytes and immune pathways in immunotherapy-treated melanoma patients.

Genes and immunity·2026

Strategic engineering B cell immunity for cancer immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2026

An Endometrioid Carcinoma With an Adenoma Malignum-like Pattern of Invasion: New Insight into Molecular Features.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·2026

Related Experiment Videos

"The immunological orchestra in cancer"

Related Concept Videos

Enhancement of activation-induced apoptosis of lymphocytes by the cytotoxic ribonuclease onconase (Ranpirnase).

A phase II trial of weekly intravenous ranpirnase (Onconase), a novel ribonuclease in patients with metastatic kidney cancer.

Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma.

Induction of differentiation of leukaemic (HL-60) or prostate cancer (LNCaP, JCA-1) cells potentiates apoptosis triggered by onconase.

Enhanced cellular radiation sensitivity of androgen-independent human prostate tumor cells by onconase.

Tumoricidal effects of onconase on various tumors.

Activated macrophage hybridomas secreting a cytotoxic factor.

Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.

Hemopoietic effects of intravenous soluble glucan administration.

Suppression of spontaneous insulin-dependent diabetes in BB rats by administration of ciamexone.

Stimulation of hematopoiesis in untreated and cyclophosphamide treated mice by the inhibition of prostaglandin synthesis.

Therapeutic effect of endogenous tumor necrosis factor on ascites Meth A sarcoma.

Tertiary lymphoid structures as biomarkers and therapeutic targets in neoadjuvant cancer immunotherapy.

The hidden tumour: giant anterior mediastinal thymolipoma, an incidental finding.

FADS1-mediated Efferocytosis in Tumor-Associated Macrophages Shapes an Immunosuppressive Microenvironment in Gastric Cancer.

The tumoural landscape of lymphocytes and immune pathways in immunotherapy-treated melanoma patients.

Strategic engineering B cell immunity for cancer immunotherapy.

An Endometrioid Carcinoma With an Adenoma Malignum-like Pattern of Invasion: New Insight into Molecular Features.

Related Experiment Videos

"The immunological orchestra in cancer"

Related Concept Videos

Related Articles